Encision Inc. (OTCMKTS:ECIA – Get Free Report) was the recipient of a large growth in short interest in August. As of August 15th, there was short interest totalling 6,800 shares, a growth of 21.4% from the July 31st total of 5,600 shares. Based on an average daily trading volume, of 25,600 shares, the short-interest ratio is presently 0.3 days.
Encision Price Performance
ECIA stock remained flat at $0.37 during trading on Friday. 65,500 shares of the company’s stock were exchanged, compared to its average volume of 13,674. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.99 and a quick ratio of 0.84. The stock has a market cap of $4.39 million, a P/E ratio of -9.25 and a beta of 0.58. The stock has a 50 day moving average price of $0.36 and a 200 day moving average price of $0.46. Encision has a twelve month low of $0.12 and a twelve month high of $0.75.
Encision (OTCMKTS:ECIA – Get Free Report) last released its quarterly earnings data on Monday, July 15th. The medical device company reported ($0.03) EPS for the quarter. Encision had a negative return on equity of 34.84% and a negative net margin of 11.59%. The business had revenue of $1.53 million during the quarter.
Encision Company Profile
Encision Inc, a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. The company provides active electrode monitoring (AEM) surgical instruments and monitors that enhance patient safety and patient outcomes in laparoscopic surgical procedures.
See Also
- Five stocks we like better than Encision
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Birkenstock’s Sudden Slide—Why It Might Be Your Next Big Win
- What is a Death Cross in Stocks?
- Why Dell Can Continue Winning in AI and Beyond
- Insider Buying Explained: What Investors Need to Know
- Veeva’s Stock Jumps on Stellar Q2 Results—Don’t Miss Out
Receive News & Ratings for Encision Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encision and related companies with MarketBeat.com's FREE daily email newsletter.